Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
19 Jan 2017 | 2:05 AM
 

Divi`s Laboratories Ltd. Share Price Live (BSE)
0

BSE Code: 532488 | NSE Symbol: DIVISLAB
739.10
2.21
(0.30 %)
18 Jan 2017 | 04:01 PM
Change company
  • Open (Rs)
    741.85
  • Prev. close (Rs.)
    736.90
  • High (Rs.)
    747.00
  • Low (Rs.)
    736.20
  • 52W H (Rs.)
    1,380.00
  • 52W L (Rs.)
    729.00
  • Volume (Rs.)
    122575
  • MCap (Rs in Cr.)
    19,620.82
741.7
1.15
(0.16 %)
  • Open (Rs)
    742.95
  • High (Rs)
    745.00
  • Low (Rs)
    738.50
  • Prev. close(Rs)
    740.55
  • Contracts Tra.
    2,72,400
  • Turnover (Cr.)
    20
  • Open Interest
    65,10,000
  • Open Int. chg
    2,82,600.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
64.15
Operating Margin (%)
37.40
Gross Profit Margin (%)
33.04
Net Profit Margin (%)
27.33
Total Debt/Equity
0.01
Dividend payout Ratio (Net Profit)
37.52
Earning Retention Ratio
62.48

News

08 Dec 2016 - 10:51:00-Shares of Divi's Laboratories plunged over 6 per cent on the Bombay Stock Exchange after the com...
16 Aug 2016 - 13:06:00-Hyderabad-based pharma company Divis Laboratories Ltd has reported a growth of 23...
16 Aug 2016 - 12:08:00-Shares of Divi's Laboratories soared over 6 per cent hitting 52-week high on the Bombay Stock Ex...
22 Feb 2016 - 11:12:00-Shares of Divi's Laboratories rose over 1 per cent on Bombay Stock Exchange (BSE) after the drug...

Announcements

16-Jan-2017
Divi`s Lab - Shareholding for the Period Ended December 31 2016
10-Jan-2017
Divi`s Lab - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended December 31
09-Jan-2017
Divi`s Lab - Update on US-FDA inspection of Unit-II at Visakhapatnam
23-Dec-2016
Divi`s Lab - Clarification sought from Divis Laboratories Ltd
23-Dec-2016
Divi`s Lab - Clarifies on News Item

Religare Research

18 Jan 2017 | 10:47 AM
Agri Technical report
18 Jan 2017 | 10:10 AM
Agri Fundamental report
18 Jan 2017 | 10:01 AM
The Indian rupee rose to a more-than-one-week high against the dollar amid choppy trade, tracking ga...
18 Jan 2017 | 09:52 AM
• Brexit plus Trump have sent gold on a January winning streak • Oil steady; record high Russian out...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
24,33,441 575.29 75.02 0.53
24,33,441 575.29 30.55 0.53
24,33,441 575.29 75.02 0.53
24,33,441 575.29 19.95 0.53
24,33,441 575.29 77.21 0.53

Shareholding Pattern

       
Promotors52.06%
Mutual Funds/UTI14.29%
FI/Banks0.29%
Insurance0.29%
FII19.81%
Government0.00%
Others6.56%

Peer Group

Company Intraday Graph
 Dr. Reddy`s Laboratories Ltd.
2,953.35(-0.81)
3294
 GlaxoSmithKline Pharmaceuticals Ltd.
2,744.75(1.05)
3317
 Piramal Enterprises Ltd.
1,840.25(2.76)
3356
 Ajanta Pharma Ltd.
1,785.00(-0.38)
3790

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Divi``s Laboratories Ltd.-421.75-544.80-407.95
NIFTY(S&P CNX)312.65-260.90-91.70
BSE SENSEX882.94-793.24-489.02
BSE 500507.86-393.45173.95

Corporate Details

Key Personal
Kiran S Divi
President & Director
Madhusudana Rao Divi
Director - Projects
Murali K Divi
Chairman & Managing Director
Key Address
Registered Office
1-72/23(P)/DIVIS/303 Divi Towers Cyber Hills Gachibowli,Hyderabad,Telangana

Tel:040-23786300, Fax:040-23786460

mail@divislaboratories.com
http://www.divislaboratories.com
Registrar Office
In House

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Divi`s Laboratories Ltd. that will help you decide whether to buy, sell or hold Divi`s Laboratories Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Divi`s Laboratories Ltd.

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.